Brand profile · Biotechnology Research

Neurocyte

Neurocyte is a Biotechnology Research brand in Singapore. Privately held, at neurocyte-bio.com. Two addresses sit on record, spread over two office countries. It employs 2 people, on the record. One Singapore registration (UEN) is a confirmed match. It is listed alongside two similar brands, mostly in Biotechnology.

Profile live Privately Held 1 entity UEN 2 office countries
Registry verified · ACRA

Key facts

Counted staff
2
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ACRA
Office countries
2
2 addresses
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity

Legal entities

Neurocyte: 1 registry entityNeurocyte is linked to 1 registry entity: NEUROCYTE PTE. LTD. (UEN 202103499M, confirmed).NeurocyteNEUROCYTE PTE. LTD.UEN 202103499MConfirmed · ACRA
Show as table · Neurocyte: 1 registry entity
Neurocyte: 1 registry entity
NEUROCYTE PTE. LTD.UEN 202103499M
Confirmed matches1 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Neurocyte is a high-tech company dedicated to developing treatment solutions for brain diseases. Headquartered in Singapore, the company has established R&D centers in Shanghai, China, and Australia, and a clinical trial base in Beijing, China. Neurocyte has an international research team composed of scientists from Australia, Singapore, and China.

One of the company's patented technologies is a novel therapeutic approach that utilizes extracellular vesicles to deliver bioactive substances. Leveraging this technology platform, Neurocyte has partnered with leading experts in the field of brain neuroscience in China to conduct in-depth research on stroke, a major public health issue. As the second leading cause of death in the world and the leading cause of death in China, stroke has long been a huge challenge in the medical community. At present, the exosome products developed by Neurocyte have entered the IIT (early clinical trial) stage, and preliminary results show good efficacy and safety, which marks a significant milestone for the company in addressing this problem.

For more information, please refer to our website.

Locations

2
Countries with an office address2 addresses on record

Country footprint

Offices in 2 countriesCountry footprint: 2 countries, primary SG. Codes: SG, CN.2 countriesprimary SGSGCN
Show as table · Offices in 2 countries
Offices in 2 countries
Countries2
Primary countrySG

All codes: SG CN

Addresses

  • SG1 Venture Avenue, Singapore; #01-08, Perennial Business City; Singapore, 608521Primary
  • CNZhangjiang Town, Pudong New Area; ATLATL Innovation R&D Center; Shanghai

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

FAQ

Which legal entity operates under Neurocyte?

One Singapore entity on ACRA: NEUROCYTE PTE. LTD. (UEN 202103499M), high confidence.

How many people work at Neurocyte?

2 counted staff profiles at January 2026, inside the self-reported 2–10 band.

Where does Neurocyte have offices?

Two addresses on record across 2 countries. Primary: 1 Venture Avenue, Singapore, #01-08, Perennial Business City, Singapore 608521.

Has Neurocyte raised funding?

None linked to this brand.

Which companies are listed alongside Neurocyte?

1 profile lists Neurocyte as a peer — 30th percentile in Biotechnology Research. It lists four peers of its own. Neocytogen Theraputics lists it back.

What is Neurocyte's website?